Recently, we have provided evidence that cannabinoids confer tumor-to-endothelial interaction via upregulation of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) release from lung cancer cells, resulting in a decrease in angiogenic features of human umbilical vein endothelial cells (HUVECs) [25]. The gene discussed is TIMP1; the disease is lung cancer.